AbbVie, Inc.AbbVie, Inc.AbbVie, Inc.

AbbVie, Inc.

거래 없음

회사 부채 증권

아래는 만기 수익률을 기준으로 정렬된 AbbVie, Inc. 채권 목록입니다. 투자자들은 종종 시장 변동성이 심한 시기에 안정성을 높이기 위해 회사채를 선택합니다. 가격, 수익률 및 기타 통계를 살펴보고 신뢰할 수 있는 투자처를 찾아보세요.
심볼
YTM %
거래량
가격 %
쿠폰 %
머튜어리티 데이트
미결제 금액
액면가
최소 액면 금액
발행자
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7.00%26 K76.04%4.750%2045-03-1553.51 M USD1,000.00 USD2,000.00 USD
Allergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6.40%12 K83.25%4.850%2044-06-1565.23 M USD1,000.00 USD2,000.00 USD
Allergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6.38%124 K81.98%4.625%2042-10-0167.49 M USD1,000.00 USD2,000.00 USD
Actavis, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5.79%250 K91.22%4.550%2035-03-15107.65 M USD1,000.00 USD2,000.00 USD
Allergan Funding SCS
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.69%1.16 M96.91%5.500%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.61%768 K96.49%5.400%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5.61%127 K100.12%5.600%2055-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
5.59%086.45%4.450%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.58%316 K90.95%4.875%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5.57%7.13 M82.31%4.250%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
5.55%090.12%4.700%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.51%120 K92.64%4.850%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.50%191 K91.05%4.750%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.49%26 K90.47%3.200%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.45%1.74 M98.83%5.350%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US00287YAM12AbbVie Inc. 4.4% 06-NOV-2042
5.43%088.89%4.400%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.36%765 K91.34%4.625%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.18%6.54 M88.96%4.050%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
4.89%095.31%4.300%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
4.81%097.73%4.500%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4.78%1.77 M103.02%5.200%2035-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4.76%15.51 M98.48%4.550%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4.66%4.23 M102.47%5.050%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.24%2.1 M103.21%4.950%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
4.09%1.93 M102.88%4.875%2030-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.06%18.21 M96.99%3.200%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
3.98%2.19 M102.37%4.800%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
3.93%099.82%3.200%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3.85%2.21 M100.92%4.250%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
3.84%1.25 M101.62%4.650%2028-03-151.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3.81%18.64 M100.99%4.800%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3.81%4.66 M99.30%2.950%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
3.65%095.31%2.125%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EUR
Allergan Funding SCS
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
3.61%097.44%2.625%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EUR
Allergan Funding SCS
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3.16%0126.76%4.750%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
3.13%0128.71%4.850%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3.13%0121.31%4.250%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
3.02%090.74%1.250%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
2.60%098.49%2.125%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.57%0123.74%4.550%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
2.55%098.87%2.125%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
2.52%0100.29%2.625%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
2.39%097.16%0.750%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
−5.92%098.80%2.950%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
4.400%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.